DEVELOPING BREAKTHROUGH BIOLOGICS, LIFE-CHANGING MEDICINES Trademark

Trademark Overview


On Wednesday, February 12, 2020, a trademark application was filed for DEVELOPING BREAKTHROUGH BIOLOGICS, LIFE-CHANGING MEDICINES with the United States Patent and Trademark Office. The USPTO has given the DEVELOPING BREAKTHROUGH BIOLOGICS, LIFE-CHANGING MEDICINES trademark a serial number of 88794868. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by MacroGenics, Inc.. The DEVELOPING BREAKTHROUGH BIOLOGICS, LIFE-CHANGING MEDICINES trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

New product commercialization services, namely, commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases

Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
developing breakthrough biologics, life-changing medicines

General Information


Serial Number88794868
Word MarkDEVELOPING BREAKTHROUGH BIOLOGICS, LIFE-CHANGING MEDICINES
Filing DateWednesday, February 12, 2020
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6173390
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements


Goods and ServicesNew product commercialization services, namely, commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
Goods and ServicesDiscovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 18, 2020
Primary Code035
First Use Anywhere DateTuesday, June 4, 2019
First Use In Commerce DateTuesday, June 4, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 18, 2020
Primary Code042
First Use Anywhere DateTuesday, June 4, 2019
First Use In Commerce DateTuesday, June 4, 2019

Trademark Owner History


Party NameMacroGenics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameMacroGenics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameMacroGenics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Thursday, January 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 22, 2020ASSIGNED TO LIE
Friday, June 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 8, 2020NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, May 8, 2020PRIORITY ACTION E-MAILED
Friday, May 8, 2020PRIORITY ACTION WRITTEN
Thursday, April 30, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 15, 2020NEW APPLICATION ENTERED